WebJun 13, 2024 · Editas Medicine's new CEO, Gilmore O'Neill, has hit the ground running to move the company forward into its next phase. Less than a week after taking the helm at the start of this month, O'Neill brought Editas to the dealmaking table, signing a licensing deal to provide gene editing tools to German immunotherapy company Immatics.. PharmaVoice … WebJan 21, 2024 · CAMBRIDGE, Mass., Jan. 20, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading gene editing company, today announced the pricing of an underwritten offering of 3,500,000...
Editas Medicine
Web18 hours ago · For their last quarter, Editas Medicine (EDIT) reported earnings of -$0.88 per share, missing the Zacks Consensus Estimate of -$0.84 per share. This reflects a negative … WebJan 9, 2024 · Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. Editas Medicine is the exclusive ... explain how to use a fitbit watch versa 2
EDITS 2024 - emema.org
WebApr 28, 2024 · Jim Mullen, Editas’ Chairman, President and CEO, who will become Executive Chairman on June 1. Mullen: Data this year would be actually our EDIT-101 in LCA, and we’ve guided to that. We’ll ... Web2 days ago · Emma Reeve to support Editas’ evolution in new role as Chair of the Board. Elliott Levy, M.D., joins Board as an Independent Director. CAMBRIDGE, Mass., April 13, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical stage genome editing company, today announced the appointment of current Independent Director Emma … WebApr 13, 2024 · CAMBRIDGE, Mass., April 13, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical stage genome editing company, today announced the appointment of current Independent Director ... explain how to win candy crush level 532